DMYD - TSLA NVTA CHPT and NNOX among premarket gainers
Nano-X Imaging (NNOX) +68% as FDA OKs 510(k) for Single Source Nanox.ARC Digital X-Ray.Chembio Diagnostics (CEMI) +48%.NanoVibronix (NAOV) +24%.Leaf Group Ltd. (LEAF) +19% on being acquired by Graham Holdings for $8.50 per share.dMY Technology Group (DMYD) +19%.Hoth Therapeutics (HOTH) +11%.Bio-Path Holdings (BPTH) +17% after mid-stage leukemia trial update.FG Financial Group (FGF) +16%.Cidara Therapeutics (CDTX) +13% on agreement with Janssen to develop and commercialize AVCs.electroCore (ECOR) +10% after regulatory approval in CanadaAirNet Technology (ANTE) +11%.Invitae Corporation (NVTA) +11% on Genosity acquisition.BIO-key International (BKYI) +7% on contract extension.Vivos Therapeutics (VVOS) +10%.Chargepoint Holdings (CHPT) +9%.Mereo BioPharma Group plc (MREO) +9%.Ocuphire Pharma (OCUP) +9%.Atlantic American Corporation (AAME) +8%.BriaCell Therapeutics Corp. (BCTX) +8%.Seneca Biopharma (SNCA) +11%.Tesla (TSLA) +7%.500.com Limited (WBAI) +7% on preference shares issuance.Can-Fite BioPharma (CANF) +7% on pre-clinical update of CBD rich T3/C15 cannabis.Uranium Energy Corp. (UEC) +7%.Supernus Pharmaceuticals, Inc. (SUPN) +7%.
For further details see:
TSLA, NVTA, CHPT and NNOX among premarket gainers